Literature DB >> 12423381

Systemic overexpression of the alpha 1B-adrenergic receptor in mice: an animal model of epilepsy.

Takeharu Kunieda1, Michael J Zuscik, Atthaporn Boongird, Dianne M Perez, Hans O Lüders, Imad M Najm.   

Abstract

PURPOSE: A lack of selective alpha1-adrenergic receptor (alpha1-ARs) agonists and antagonists has made it difficult to clarify the precise function of these receptors in the CNS. We recently generated transgenic mice that overexpress either wild-type or a constitutively active mutant alpha 1B-AR in tissues that normally express the receptor. Both wild-type and mutant mice showed an age-progressive neurodegeneration with locomotor impairment and probable stress-induced motor events, which can be partially reversed by alpha 1-AR antagonists. We hypothesized that the wild-type and mutant mice may exhibit spontaneous epileptogenicity as compared with normal (nontransgenic) mice.
METHODS: Normal, wild-type, and mutant mice were studied. Twenty mice (1 year old) underwent prolonged video-EEG monitoring over a 4-week period. Raw EEG data were blindly analyzed by visual inspection for the presence of interictal and ictal epileptic activities.
RESULTS: During the acute postoperative period (< or = 3 days), both wild-type (26.1 +/- 8.07 spikes/day) and mutant mice (116.87 +/- 55.13) exhibited more frequent interictal spikes than did normal mice (2.17 +/- 0.75; p value, <0.05), but all three groups showed EEG and clinical seizures. During the later monitoring periods (>3 days), wild-type and mutant mice showed more frequent interictal spikes (15.44 +/- 4.07; p < 0.01; and 6.05 +/- 2.46; p < 0.05, respectively) as compared with normal mice (0.41 +/- 0.41), but only mutant mice had spontaneous clinical seizures (means +/- SEM).
CONCLUSIONS: The selective overexpression of the alpha 1B-AR is associated with increased in vivo spontaneous interictal epileptogenicity and EEG/behavioral seizures. These results suggest a possible role (direct or indirect) for the alpha 1B-ARs in the development and expression of epileptogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423381     DOI: 10.1046/j.1528-1157.2002.13202.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Haplotype block and superblock structures of the alpha1-adrenergic receptor genes reveal echoes from the chromosomal past.

Authors:  B Buzas; I Belfer; H Hipp; I Lorincz; C Evans; G Phillips; J Taubman; M B Max; D Goldman
Journal:  Mol Genet Genomics       Date:  2004-10-16       Impact factor: 3.291

Review 2.  Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.

Authors:  Dianne M Perez; Van A Doze
Journal:  J Recept Signal Transduct Res       Date:  2011-02-21       Impact factor: 2.092

3.  Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures.

Authors:  Rafal M Kaminski; Toni S Shippenberg; Jeffrey M Witkin; Beatriz A Rocha
Journal:  Neurosci Lett       Date:  2005-03-19       Impact factor: 3.046

4.  Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.

Authors:  Sylvia Stemberger; Werner Poewe; Gregor K Wenning; Nadia Stefanova
Journal:  Exp Neurol       Date:  2010-05-21       Impact factor: 5.330

Review 5.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

Review 6.  Animal models of multiple system atrophy.

Authors:  Nadia Stefanova; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2015-01-14       Impact factor: 4.435

Review 7.  Towards translational therapies for multiple system atrophy.

Authors:  Daniela Kuzdas-Wood; Nadia Stefanova; Kurt A Jellinger; Klaus Seppi; Michael G Schlossmacher; Werner Poewe; Gregor K Wenning
Journal:  Prog Neurobiol       Date:  2014-03-02       Impact factor: 11.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.